Formula research

Glyco Barrier Ingredients & Scientific Research

A deeper ingredient-by-ingredient analysis of the publicly disclosed formula, including what human studies suggest, where evidence is mixed, and why undisclosed doses matter.

Reviewed and updated: September 22, 2026

Looking for a broader category guide?See how chromium, Gymnema, green tea and ginseng are evaluated across natural blood sugar support supplements, including what human research can—and cannot—tell us.
Key interpretation ruleResearch on an ingredient cannot be used as proof that the finished supplement produces the same result. This is especially important here because Glyco Barrier discloses the blend as 200 mg total but does not provide the individual amounts of the listed botanicals.
Glyco Barrier bottle held in a hand
Formula at a glance

What the public product description identifies

Glyco Barrier is described as combining Chromium Picolinate with a 200 mg proprietary herbal blend containing 20 ingredients. The description names Gymnema Sylvestre, Ginseng Root, Green Tea Leaf Extract and Maca Root.[11]

The key limitation is not whether those ingredients are present; it is that the complete blend breakdown and individual botanical amounts are not provided in the description reviewed.

Why that matters scientificallyClinical studies typically use a defined ingredient, extract, dose, population and duration. Without the per-ingredient amounts and extract specifications, Glyco Barrier cannot be assumed to match the preparations used in published trials.
Evidence table

Ingredient research related to glucose metabolism

This table summarizes the most relevant evidence we found without converting ingredient research into a claim about the finished product.

IngredientRole in the formulaResearch related to glucose/metabolismMain limitationScientific source
Chromium PicolinateDeclared separately from the herbal blend.Chromium is involved in macronutrient metabolism and has been studied for glycemic control. Meta-analyses report possible benefits in diabetes, while evidence outside diabetes is less convincing.Product dose of chromium was not available in the text description we reviewed; study results vary by dose, chromium form and population.Suksomboon et al., 2014
NIH ODS Chromium
Gymnema SylvestreNamed within the 200 mg proprietary blend.A systematic review/meta-analysis of 10 studies reported changes in fasting glucose, post-meal glucose and HbA1c; a small placebo-controlled trial also examined impaired glucose tolerance.Very high heterogeneity in the meta-analysis and no disclosed Gymnema amount in Glyco Barrier.Devangan et al., 2021
Clinical trial, PMID 32460589
Green Tea Leaf ExtractNamed within the proprietary blend.A meta-analysis of 27 randomized trials found a small reduction in fasting glucose but no significant overall effect on fasting insulin or HbA1c.Green-tea products vary substantially; Glyco Barrier does not state the extract standardization, amount or caffeine content in the description reviewed.Xu et al., 2020
NCCIH Green Tea
Ginseng RootNamed within the proprietary blend.A meta-analysis of Panax ginseng trials reported a modest reduction in fasting glucose, with no significant overall effect on several other glycemic markers.The product description says only “Ginseng Root”; it does not specify that the ingredient is Panax ginseng, so Panax findings cannot be directly assigned to the product.Shishtar et al., 2014
NCCIH Asian Ginseng
Maca RootNamed within the proprietary blend.Human trials have studied maca primarily for other outcomes. One randomized study reported a glucose change with black maca, while another found no glucose difference versus placebo.The product does not specify maca variety/extract or dose, and the overall human evidence is not strong enough to present maca as a primary glucose-control ingredient.Gonzales-Arimborgo et al., 2016
PMID 24931003
Ingredient analysis

Chromium Picolinate

Chromium is a trace element involved in carbohydrate, lipid and protein metabolism. The NIH notes that chromium may influence insulin action, although the precise biological mechanism remains unresolved.[1]

Clinical evidence is not uniform. A 2014 systematic review and meta-analysis of randomized trials reported improvements in some glycemic measures among people with diabetes and noted stronger signals in some chromium-picolinate studies.[2]

Important for Glyco BarrierThe public product description identifies Chromium Picolinate, but the text reviewed does not provide a chromium amount. That prevents a direct comparison with doses used in published trials.
Ingredient analysis

Gymnema Sylvestre

A 2021 systematic review and meta-analysis included 10 studies with 419 participants and reported reductions in fasting glucose, postprandial glucose and HbA1c after Gymnema supplementation. However, heterogeneity was high, meaning study results differed substantially.[3]

A separate randomized, double-blind, placebo-controlled study in people with impaired glucose tolerance used a defined Gymnema preparation and measured fasting glucose, A1c, oral-glucose-tolerance and insulin-related outcomes.[4]

Why we do not call this a “clinically studied dose”Glyco Barrier places Gymnema inside a 200 mg blend with many ingredients and does not disclose the individual Gymnema amount in the description reviewed. The trial doses therefore cannot be mapped directly onto the product.
Ingredient analysis

Green Tea Leaf Extract

Green tea has been studied extensively, but glucose-related results vary. A 2020 meta-analysis of 27 randomized trials involving 2,194 participants reported a small reduction in fasting glucose, while fasting insulin and HbA1c were not significantly changed overall.[5]

Safety depends on preparation and dose. NCCIH notes that green-tea extract supplements can cause gastrointestinal symptoms and increased blood pressure, and rare liver injury has been reported, particularly with concentrated extract products.[6]

Product-specific unknownsThe product description reviewed does not state the green-tea extract amount, catechin standardization or caffeine content. We therefore do not label Glyco Barrier “caffeine-free” or “stimulant-free.”
Ingredient analysis

Ginseng Root

A systematic review and meta-analysis of 16 randomized controlled trials involving the genus Panax reported a modest reduction in fasting glucose but no significant overall effect on fasting insulin, HbA1c or HOMA-IR.[7]

NCCIH similarly describes research on Asian ginseng and blood-sugar control as inconclusive and conflicting overall.[8]

Species mattersThe Glyco Barrier description says “Ginseng Root” without specifying species. We therefore do not assume the ingredient is Panax ginseng, American ginseng or another preparation, and we do not directly apply Panax trial results to the finished product.
Ingredient analysis

Maca Root

Maca has human clinical research, but most of it is not centered on glucose control. In a 2016 randomized trial of red and black maca extracts, black maca was associated with lower blood glucose in that study context.[9]

By contrast, a randomized crossover study in postmenopausal women reported no glucose difference between maca and placebo.[10]

Our interpretationThe evidence is too limited and preparation-specific to describe generic “Maca Root” as a primary blood-sugar ingredient. We treat it as a botanical present in the formula, with limited direct evidence for the product’s glucose-oriented positioning.
Formula transparency

What is still not publicly disclosed in the description reviewed

15 additional blend ingredients

The product description states that the blend contains 20 ingredients but names only a subset. We do not guess the remaining components.

Individual botanical amounts

The 200 mg figure applies to the proprietary blend as a whole, not to each listed herb.

Extract specifications

Species, standardization, active-compound content and caffeine content are not consistently provided in the text description reviewed.

Scientific references

Bibliography

[1] Chromium — Fact Sheet for Health Professionals

National Institutes of Health, Office of Dietary Supplements.

View source

[2] Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes

Suksomboon N, Poolsup N, Yuwanakorn A. Journal of Clinical Pharmacy and Therapeutics. 2014;39(3):292–306. DOI: 10.1111/jcpt.12147.

View source

[3] The effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: A systematic review and meta-analysis

Devangan S, Varghese B, Johny E, Gurram S, Adela R. Phytotherapy Research. 2021;35(12):6802–6812. DOI: 10.1002/ptr.7265.

View source

[4] Effect of Gymnema sylvestre Administration on Glycemic Control, Insulin Secretion, and Insulin Sensitivity in Patients with Impaired Glucose Tolerance

Randomized, double-blind, placebo-controlled clinical trial. Journal of Medicinal Food. 2020. PMID: 32460589.

View source

[5] Effects of green tea consumption on glycemic control: a systematic review and meta-analysis of randomized controlled trials

Xu R, Bai Y, Yang K, Chen G. Nutrition & Metabolism. 2020;17:56. DOI: 10.1186/s12986-020-00469-5.

View source

[6] Green Tea: Usefulness and Safety

National Center for Complementary and Integrative Health.

View source

[7] The Effect of Ginseng (The Genus Panax) on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials

Shishtar E, Sievenpiper JL, Djedovic V, et al. PLOS ONE. 2014;9(9):e107391. DOI: 10.1371/journal.pone.0107391.

View source

[8] Asian Ginseng: Usefulness and Safety

National Center for Complementary and Integrative Health.

View source

[9] Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (Lepidium meyenii) in Adult Human Subjects: A Randomized, Double-Blind, Placebo-Controlled Study

Gonzales-Arimborgo C, et al. Pharmaceuticals (Basel). 2016;9(3):49. DOI: 10.3390/ph9030049.

View source

[10] Maca reduces blood pressure and depression, in a pilot study in postmenopausal women

Randomized, double-blind, placebo-controlled crossover study. Climacteric. PMID: 24931003.

View source

[11] Glyco Barrier — public product information

Manufacturer/marketer product page reviewed September 2026. Used for formula, directions, package and guarantee statements; commercial claims are treated as manufacturer-reported.

View source
Glyco BarrierSee current pricing and availability
Check Current Price